GW Pharmaceuticals Plc. GWPRF Company Overview  Stock

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
GW Pharmaceuticals Plc. GWPRF Company Overview 

Stock Message Board http://investorshangout.com/search?q=GWPRF&am...mp;yt1=Go!

GW Pharmaceuticals Plc. GWPRF Current Price and Quotes
0.951
Previous Close
0.86
Open
0.89

Daily Range
0.955 - 0.89
52wk Range
1.30 - 0.58

Volume
19,250
Dividend
N/A

Average Vol (3m)
5,588
Yield
N/A

GW Pharmaceuticals Plc. GWPRF
Company Information
Porton Down
Science Park
Salisbury
Wilts SP4 0JQ
United Kingdom

Website: http://www.gwpharm.com
Phone: 44 (0) 1980 557000
Email: info@gwpharm.com

GW Pharmaceuticals Plc. GWPRF
GW is a pharmaceutical group developing a portfolio of cannabinoid prescription medicines to meet patient needs in a wide range of therapeutic conditions. GW is licensed by the UK Home Office to work with a range of controlled drugs for medical research purposes. The Group's lead programme is the development of a product portfolio of cannabinoid prescription medicines , including Sativex® Oromucosal Spray, to meet patient needs in a wide range of therapeutic indications
GW has assembled a ...



GW Pharmaceuticals Plc. GWPRF
Financial Reportings and Disclosures
Reporting Status International Reporting: LSE - London Stock Exchange
Fiscal Year End 9/30
OTC Marketplace OTC Pink Current
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: United Kingdom
Year of Inc. 1998
Employees 130 a/o Dec 31, 2011
Company Officers/Contacts
David Kirk Finance Director
Company Directors
Geoffrey Guy Executive Chairman
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

GW Pharmaceuticals Plc. GWPRF
GWPRF Security Details Other Company Securities
Share Structure
Market Value1 $125,103,670 a/o Aug 30, 2013
Shares Outstanding 131,549,600 a/o Mar 31, 2011
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
GWP - LSE - London Stock Exchange - Qualified
Short Selling Data
Short Interest 550 (-88.04%)
Aug 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)


GW Pharmaceuticals Plc. GWPRF Recent News

GW Pharmaceuticals Plc. GWPRF Financials
Data is unavailable at this time. Please check this page later.

GWPRF GW Pharmaceuticals Plc. Research DD Guide

GWPRF GW Pharmaceuticals Plc. Stock Message Board http://investorshangout.com/search?q=GWPRF&am...mp;yt0=Go!
GWPRF GW Pharmaceuticals Plc. Stock Quote http://www.otcmarkets.com/stock/GWPRF/quote
GWPRF GW Pharmaceuticals Plc. Stock Chart http://www.otcmarkets.com/stock/GWPRF/chart
GWPRF GW Pharmaceuticals Plc. Company Info http://www.otcmarkets.com/stock/GWPRF/company-info
GWPRF GW Pharmaceuticals Plc. Recent News http://www.otcmarkets.com/stock/GWPRF/news
GWPRF GW Pharmaceuticals Plc. Financials http://www.otcmarkets.com/stock/GWPRF/financials
GWPRF GW Pharmaceuticals Plc. Filings and Disclosure http://www.otcmarkets.com/stock/GWPRF/filings
GWPRF GW Pharmaceuticals Plc. Short Sales http://www.otcmarkets.com/stock/GWPRF/short-sales
GWPRF GW Pharmaceuticals Plc. Insider Disclosure http://www.otcmarkets.com/stock/GWPRF/insider-transactions
GWPRF GW Pharmaceuticals Plc. Research Reports http://www.otcmarkets.com/stock/GWPRF/research
GWPRF GW Pharmaceuticals Plc. Summary http://finance.yahoo.com/q?s=GWPRF
GWPRF GW Pharmaceuticals Plc. Historical Prices http://finance.yahoo.com/q/hp?s=GWPRF+Historical+Prices
GWPRF GW Pharmaceuticals Plc. Interactive Chart http://finance.yahoo.com/echarts?s=GWPRF
GWPRF GW Pharmaceuticals Plc. Basic Chart http://finance.yahoo.com/q/bc?s=GWPRF+Basic+Chart
GWPRF GW Pharmaceuticals Plc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=GWPRF+Basic+Tech.+Analysis
GWPRF GW Pharmaceuticals Plc. Headlines http://finance.yahoo.com/q/h?s=GWPRF+Headlines
GWPRF GW Pharmaceuticals Plc. Press Releases http://finance.yahoo.com/q/p?s=GWPRF+Press+Releases
GWPRF GW Pharmaceuticals Plc. Company Profile http://finance.yahoo.com/q/pr?s=GWPRF+Profile
GWPRF GW Pharmaceuticals Plc. Key Statistics http://finance.yahoo.com/q/ks?s=GWPRF+Key+Statistics
GWPRF GW Pharmaceuticals Plc. Industry http://finance.yahoo.com/q/in?s=GWPRF+Industry
GWPRF GW Pharmaceuticals Plc. Major Holders http://finance.yahoo.com/q/mh?s=GWPRF+Major+Holders
GWPRF GW Pharmaceuticals Plc. Insider Transactions http://finance.yahoo.com/q/it?s=GWPRF+Insider+Transactions
GWPRF GW Pharmaceuticals Plc. Insider Roster http://finance.yahoo.com/q/ir?s=GWPRF+Insider+Roster
GWPRF GW Pharmaceuticals Plc. Income Statement http://finance.yahoo.com/q/is?s=GWPRF
GWPRF GW Pharmaceuticals Plc. Balance Sheet http://finance.yahoo.com/q/bs?s=GWPRF
GWPRF GW Pharmaceuticals Plc. Cash Flow http://finance.yahoo.com/q/cf?s=GWPRF+Cash+Flow&annual
GWPRF GW Pharmaceuticals Plc. Nasdaq http://www.nasdaq.com/symbol/GWPRF
GWPRF GW Pharmaceuticals Plc. Market Watch http://www.marketwatch.com/investing/stock/GWPRF
GWPRF GW Pharmaceuticals Plc. Bloomberg http://www.bloomberg.com/quote/GWPRF:US
GWPRF GW Pharmaceuticals Plc. Morningstar http://quotes.morningstar.com/stock/s?t=GWPRF
GWPRF GW Pharmaceuticals Plc. Bussinessweek http://investing.businessweek.com/research/st...cker=GWPRF
GWPRF GW Pharmaceuticals Plc. Barchart http://www.barchart.com/quotes/stocks/GWPRF
GWPRF GW Pharmaceuticals Plc. OTC Short Report http://otcshortreport.com/index.php?index=GWPRF
GWPRF GW Pharmaceuticals Plc. Investopedia http://www.investopedia.com/markets/stocks/GWPRF/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Blanchard's People and Culture Team Earns Bronze Stevie Award

Updated Category News Views 83

Blanchard Honored for Excellence in HR Blanchard, a leading global firm in leadership development and consulting, has recently received the Bronze Stevie Award for Human Resources Department of the Year at the prestigious International Business Awards. This award acknowledges the innovative initiatives undertaken by Blanchard's People and Culture team, which have greatly...

Continue Reading
e.l.f. Beauty's Future: Navigating the Uncertainty Ahead

Updated Category News Views 116

Understanding e.l.f. Beauty's Current Stock Landscape e.l.f. Beauty (NYSE: ELF) has transitioned through various stock phases, culminating in a period marked by uncertainty. Having recently completed its Adhishthana Himalayan formation, the stock finds itself in a crucial structural phase. Knowing where the stock currently stands can help investors make informed decisions...

Continue Reading
AIKO Launches Groundbreaking 500W Solar Panels for Australia

Updated Category News Views 293

AIKO Unveils Revolutionary Solar Technology AIKO has successfully made a strong statement in the Australian solar market with the introduction of its Gen 3 Infinite Series portfolio. This significant launch at All Energy Australia showcases innovative technology aimed at enhancing solar energy solutions for residential, commercial, and large-scale projects. Transformative...

Continue Reading
Explore Incredible Cruise Offers with Holland America Line

Updated Category News Views 100

Unveiling Holland America's Exceptional Fare Deals Holland America Line has officially kicked off its most significant promotion of the year, the "Start Your Journey" Wave season. This offer features over 500 cruises, allowing travelers to explore stunning destinations like Alaska and Europe while enjoying up to 30% off cruise fares. With free balcony upgrades and various...

Continue Reading
Mavenir's NIaaS Achieves Recognition for AI Excellence

Updated Category News Views 90

Mavenir Achieves Recognition for Its Innovation Mavenir, a leading cloud-native network infrastructure provider, has recently been honored with the prestigious Advancing Artificial Intelligence Global Telecoms Award for its impactful service, Network Intelligence as a Service (NIaaS). This accolade demonstrates Mavenir's commitment to harnessing artificial intelligence...

Continue Reading